Marketplace Morning Report for Thursday, July 2, 2015
Jul 2, 2015

Marketplace Morning Report for Thursday, July 2, 2015

HTML EMBED:
COPY

Airing on Thursday, July 2, 2015: The Department of Justice looking into whether major U.S. airlines are illegally coordinating to keep ticket prices up. More on that. Plus, we'll talk about New York City's ban on so-called “poor doors,” the separate entrances to mixed-income buildings that were to be used by lower-income residents. Plus, a conversation with Elizabeth Holmes, who at 31 is the youngest female, self-made multibillionaire in America, according to Forbes. The company Holmes created, Theranos, developed a home blood-testing kit that could challenge the business model of medical labs.

Segments From this episode

'Poor doors' exit New York

Jul 2, 2015
The city has banned the separate entrances to mixed-income buildings.
New York City has banned “poor doors," separate entrances to mixed-income buildings.
Spencer Platt/Getty Images

U.S. rice growers want to get in on Cuba

Jul 2, 2015
The increased demand would help farmers, who have seen prices fall.

Elizabeth Holmes on democratizing medical testing

Jul 2, 2015
The multibillionaire wants to challenge the business model of medical labs.

PODCAST: Rice in Cuba

Jul 2, 2015
Jobs report for June, American rice in Cuba, and lessons to learn for the U.S.

Major airlines under investigation for collusion

Jul 2, 2015
The DOJ is looking into whether airlines have worked together to keep prices high.

Airing on Thursday, July 2, 2015: The Department of Justice looking into whether major U.S. airlines are illegally coordinating to keep ticket prices up. More on that. Plus, we’ll talk about New York City’s ban on so-called “poor doors,” the separate entrances to mixed-income buildings that were to be used by lower-income residents. Plus, a conversation with Elizabeth Holmes, who at 31 is the youngest female, self-made multibillionaire in America, according to Forbes. The company Holmes created, Theranos, developed a home blood-testing kit that could challenge the business model of medical labs.